Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1992-5-14
|
pubmed:abstractText |
The solubilization and delivery of lipids in plasma rely on both forms of apolipoprotein B (apo B): apo B-100 and apo B-48. Apo B-48 is the translational product of apo B-100 mRNA that undergoes peritranscriptional conversion of C----U, replacing codon CAA (glutamine 2,153) with the inframe stop codon (UAA). We examined mRNA editing activity in the human and the rat by reverse transcription-polymerase chain reaction primer-extension analysis of intestine and liver total RNA. In rat intestine the percentage of apo B transcripts that undergo editing increases dramatically the day before birth (from approximately 1% to 80%), whereas the rat liver acquires an adult level of editing activity during the third postnatal week (rising from approximately 8% to 30%), when weaning is completed, bile acid composition matures, and plasma thyroid hormone levels peak. In contrast to the rat, the human intestine acquires adult levels of apo B mRNA editing relatively early in fetal development, rising from 10% at 10 weeks to approximately 80% by the end of the second trimester. Our results establish that apo B mRNA editing is 1) developmentally regulated in a tissue- and species-specific manner; 2) fully developed prenatally in both human and rat intestine, suggesting a crucial role of apo B-48 in mammalian fetal adaptation to extrauterine life; and 3) acquired early in human fetal intestine, implying a potential role for apo B-48 in prenatal lipid metabolism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1049-8834
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
468-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1558838-Animals,
pubmed-meshheading:1558838-Animals, Newborn,
pubmed-meshheading:1558838-Apolipoprotein B-48,
pubmed-meshheading:1558838-Apolipoproteins B,
pubmed-meshheading:1558838-Base Sequence,
pubmed-meshheading:1558838-Gene Expression Regulation,
pubmed-meshheading:1558838-Humans,
pubmed-meshheading:1558838-Infant,
pubmed-meshheading:1558838-Intestines,
pubmed-meshheading:1558838-Liver,
pubmed-meshheading:1558838-Molecular Sequence Data,
pubmed-meshheading:1558838-Polymerase Chain Reaction,
pubmed-meshheading:1558838-RNA, Messenger,
pubmed-meshheading:1558838-Rats,
pubmed-meshheading:1558838-Rats, Inbred Strains,
pubmed-meshheading:1558838-Transcription, Genetic
|
pubmed:year |
1992
|
pubmed:articleTitle |
Ontogenetic regulation of apolipoprotein B mRNA editing during human and rat development in vivo.
|
pubmed:affiliation |
Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
|
pubmed:publicationType |
Journal Article
|